Search results

Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy.

Result type

Technology appraisal guidance

Published

21 December 2016

Evidence-based recommendations on crizotinib (Xalkori) for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer in adults.

Result type

Technology appraisal guidance

Published

21 December 2016

Evidence-based recommendations on sofosbuvir–velpatasvir (Epclusa) for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

25 January 2017

Evidence-based recommendations on everolimus (Afinitor) for advanced renal cell carcinoma after previous treatment.

Result type

Technology appraisal guidance

Published

22 February 2017

Evidence-based recommendations on apremilast (Otezla) for treating active psoriatic arthritis.

Result type

Technology appraisal guidance

Published

22 February 2017

Evidence-based recommendations on necitumumab (Portrazza) for treating locally advanced or metastatic epidermal growth factor receptor (EGFR)-expressing squamous non-small-cell lung cancer in adults who have not had chemotherapy.

Result type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on elbasvir–grazoprevir (Zepatier) for treating genotype 1 or 4 chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

26 October 2016

Evidence-based recommendations on cobimetinib (Cotellic) with vemurafenib (Zelboraf) for treating unresectable or metastatic melanoma in adults with a BRAF V600 mutation.

Result type

Technology appraisal guidance

Published

26 October 2016

Evidence-based recommendations on certolizumab pegol (Cimzia) for treating severe active rheumatoid arthritis in adults who have had a tumour necrosis factor-alpha inhibitor.

Result type

Technology appraisal guidance

Published

26 October 2016

Evidence-based recommendations on nivolumab (Opdivo) for previously treated advanced renal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

23 November 2016

Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults.

Result type

Technology appraisal guidance

Published

23 November 2016

Evidence-based recommendations on apremilast (Otezla) for treating moderate to severe plaque psoriasis in adults.

Result type

Technology appraisal guidance

Published

23 November 2016

Evidence-based recommendations on on regorafenib (Stivarga) for previously treated gastrointestinal stromal tumours in adults.

Result type

Technology appraisal guidance

Published

15 November 2017

Evidence-based recommendations on vismodegib (Erivedge) for treating basal cell carcinoma in adults.

Result type

Technology appraisal guidance

Published

22 November 2017

Evidence-based recommendations on sarilumab (Kevzara) for treating moderate to severe rheumatoid arthritis in adults.

Result type

Technology appraisal guidance

Published

1 November 2017